当期純利益、剰余金の配当、資本金他2件
- 【期間】
| 年度 | 当期純利益 | 剰余金の配当 | 資本金 | 支払補償費 | 設備投資額 - 薬品事業 |
|---|
| 2007/03 | - | | - | | 45.6億 | | - | | - | |
| 2008/03 | - | | -13.3億 | | 45.6億 | ±0% | 21百万 | | - | |
| 2009/03 | - | | -15.6億 | 赤拡 | 45.6億 | ±0% | 6百万 | -71.4% | - | |
| 2010/03 | - | | -13.7億 | 赤縮 | 45.6億 | ±0% | 113百万 | 大幅増 | - | |
| 2011/03 | 87.9億 | | -12.1億 | 赤縮 | 45.6億 | ±0% | 29百万 | -74.3% | - | |
| 2012/03 | 75.1億 | -14.6% | -12.1億 | ±0% | 45.6億 | ±0% | 11百万 | -62.1% | - | |
| 2013/03 | 101億 | +34.7% | -12.1億 | ±0% | 45.6億 | ±0% | 9百万 | -18.2% | - | |
| 2014/03 | 125億 | +23.1% | - | | 45.6億 | ±0% | 9百万 | ±0% | - | |
| 2015/03 | 118億 | -5.4% | - | | 45.6億 | ±0% | 164百万 | 大幅増 | - | |
| 2016/03 | 123億 | +4.2% | - | | 45.6億 | ±0% | 18百万 | -89% | - | |
| 2017/03 | 141億 | +15% | - | | 45.6億 | ±0% | 35百万 | +94.4% | - | |
| 2018/03 | 152億 | +7.4% | - | | 45.6億 | ±0% | - | | - | |
| 2019/03 | 139億 | -8.3% | - | | 45.6億 | ±0% | - | | 21.5億 | |
| 2020/03 | 114億 | -18% | - | | 45.6億 | ±0% | 30百万 | -14.3% | 28.3億 | +31.4% |
| 2021/03 | 114億 | -0.3% | - | | 45.6億 | ±0% | 69百万 | +130% | 21.4億 | -24.3% |
| 2022/03 | 114億 | +0.5% | - | | 45.6億 | ±0% | 16百万 | -76.8% | 10.6億 | -50.5% |
| 2023/03 | 122億 | +6.3% | - | | 45.6億 | ±0% | - | | 10.8億 | +2.3% |
| 2024/03 | 155億 | +27.7% | - | | 45.6億 | ±0% | - | | - | |
